Susquehanna International Group’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-251,213
| Closed | -$1.01M | – | 12748 |
|
|
2025
Q1 | $1.01M | Sell |
251,213
-227,592
| -48% | -$759K | ﹤0.01% | 7228 |
|
|
2024
Q4 | $1.53M | Buy |
478,805
+386,663
| +420% | +$1.31M | ﹤0.01% | 5910 |
|
|
2024
Q3 | $206K | Buy |
92,142
+31,003
| +51% | +$71.5K | ﹤0.01% | 10407 |
|
|
2024
Q2 | $131K | Buy |
61,139
+4,714
| +8% | +$8.39K | ﹤0.01% | 10825 |
|
|
2024
Q1 | $116K | Sell |
56,425
-38,637
| -41% | -$77.1K | ﹤0.01% | 11121 |
|
|
2023
Q4 | $218K | Buy |
95,062
+40,120
| +73% | +$87.4K | ﹤0.01% | 10501 |
|
|
2023
Q3 | $93.4K | Buy |
54,942
+37,157
| +209% | +$84.4K | ﹤0.01% | 10975 |
|
|
2023
Q2 | $43.9K | Buy |
17,785
+7,340
| +70% | +$20K | ﹤0.01% | 11387 |
|
|
2023
Q1 | $23.5K | Sell |
10,445
-13,584
| -57% | -$68.2K | ﹤0.01% | 12004 |
|
|
2022
Q4 | $123K | Buy |
24,029
+22,724
| +1,741% | +$164K | ﹤0.01% | 10741 |
|
|
2022
Q3 | $14K | Sell |
1,305
-360
| -22% | -$4.29K | ﹤0.01% | 12715 |
|
|
2022
Q2 | $17K | Sell |
1,665
-13,773
| -89% | -$180K | ﹤0.01% | 12398 |
|
|
2022
Q1 | $273K | Sell |
15,438
-68,962
| -82% | -$1.48M | ﹤0.01% | 10494 |
|
|
2021
Q4 | $2.63M | Buy |
84,400
+47,965
| +132% | +$1.59M | ﹤0.01% | 4901 |
|
|
2021
Q3 | $1.2M | Buy |
36,435
+13,707
| +60% | +$405K | ﹤0.01% | 7066 |
|
|
2021
Q2 | $670K | Buy |
+22,728
| New | +$630K | ﹤0.01% | 8852 |
|
|
2021
Q1 | – | Sell |
-1,002
| Closed | -$27K | – | 12282 |
|
|
2020
Q4 | $27K | Buy |
+1,002
| New | +$25.4K | ﹤0.01% | 10858 |
|
|
2020
Q2 | – | Sell |
-1,994
| Closed | -$30K | – | 10189 |
|
|
2020
Q1 | $30K | Buy |
+1,994
| New | +$35.3K | ﹤0.01% | 9827 |
|
|
2019
Q4 | – | Sell |
-1,683
| Closed | -$42K | – | 9785 |
|
|
2019
Q3 | $42K | Sell |
1,683
-1,472
| -47% | -$40.4K | ﹤0.01% | 9827 |
|
|
2019
Q2 | $96K | Buy |
+3,155
| New | +$124K | ﹤0.01% | 9616 |
|
|
2019
Q1 | – | Sell |
-1,323
| Closed | -$24K | – | 8900 |
|
|
2018
Q4 | $24K | Buy |
+1,323
| New | +$31.5K | ﹤0.01% | 8647 |
|
|
2018
Q3 | – | Sell |
-1,299
| Closed | -$39K | – | 9289 |
|
|
2018
Q2 | $39K | Buy |
+1,299
| New | +$44.9K | ﹤0.01% | 9324 |
|
Susquehanna International Group's CKPT Position: Q2 2025 in Review
Susquehanna International Group sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 251,213 shares — an estimated $1.01M sold.
Susquehanna International Group first reported a position in CKPT in Q2 2018 and held it in 22 quarters. The position peaked at $2.63M in Q4 2021. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.
- Susquehanna International Group reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
- Susquehanna International Group sold 251,213 Checkpoint Therapeutics shares in Q2 2025, an estimated $1.01M.
- Susquehanna International Group first reported a position in Checkpoint Therapeutics in Q2 2018 and held it in 22 quarters.
- Susquehanna International Group's Checkpoint Therapeutics position peaked at $2.63M in Q4 2021.
- 0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.